Modulating ERα for Multi-system Rejuvenation
The team will test whether an orally bioavailable compound that crosses the blood–brain barrier and targets energy homeostasis, lipid metabolism, and inflammation will improve aging outcomes.
The team will test whether an orally bioavailable compound that crosses the blood–brain barrier and targets energy homeostasis, lipid metabolism, and inflammation will improve aging outcomes.